Pediatric Nephrology

, 24:1901 | Cite as

Treatment-based literature of Henoch–Schönlein purpura nephritis in childhood

  • Marco Zaffanello
  • Vassilios Fanos


Considerable concern has been expressed on the importance of identifying an improved therapeutic protocol for use in the treatment of childhood Henoch–Schönlein purpura nephritis, primarily due to the unpredictable success shown to date in improving long-term renal outcome. This review focuses on published reports describing the outcomes of therapeutic approaches currently being used in the treatment of pediatric Henoch–Schönlein purpura nephritis, with the aim of providing information that will facilitate a treatment-based approach in children presenting with varying degrees of kidney disease. The conclusions of the authors of this review are that currently prescribed treatments of children affected by Henoch–Schönlein purpura nephritis are not adequately guided by evidence obtained in properly designed, randomized, placebo-controlled trials with outcome markers related to the progression to end stage renal disease (level I evidence). Moreover, firm evidence supporting the best practice to be applied with the aim of delaying the progression of kidney disease is still lacking.


Children Evidence-based approach Glomerulonephritis Henoch–Schönlein purpura 



angiotensin converting enzyme inhibitor




cyclosporine A




end stage renal disease


Henoch–Schönlein purpura


Henoch–Schönlein purpura nephritis


mycophenolate mofetil




plasma exchange




randomized controlled trial


Declaration of competing interests

The authors declare the absence of competing interests.


  1. 1.
    Wyatt RJ, Hogg RJ (2001) Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 16:156–167PubMedCrossRefGoogle Scholar
  2. 2.
    Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202PubMedCrossRefGoogle Scholar
  3. 3.
    Kaku Y, Nohara K, Honda S (1998) Renal involvement in Henoch–Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 53:1755–1759PubMedCrossRefGoogle Scholar
  4. 4.
    Sano H, Izumida M, Shimizu H, Ogawa Y (2002) Risk factors of renal involvement and significant proteinuria in Henoch–Schönlein purpura. Eur J Pediatr 161:196–201PubMedCrossRefGoogle Scholar
  5. 5.
    Oner A, Tinaztepe K, Erdogan O (1995) The effect of triple therapy on rapidly progressive type of Henoch–Schönlein nephritis. Pediatr Nephrol 9:6–10PubMedCrossRefGoogle Scholar
  6. 6.
    Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL (2005) Renal manifestations in Henoch–Schönlein purpura: a 10-year clinical study. Pediatr Nephrol 20:1269–1272PubMedCrossRefGoogle Scholar
  7. 7.
    Davin JC, Weening JJ (2003) Diagnosis of Henoch–Schönlein purpura: renal or skin biopsy? Pediatr Nephrol 18:1201–1203PubMedCrossRefGoogle Scholar
  8. 8.
    Algoet C, Proesmans W (2003) Renal biopsy 2–9 years after Henoch–Schönlein purpura. Pediatr Nephrol 18:471–473PubMedGoogle Scholar
  9. 9.
    Stewart M, Savage JM, Bell B, McCord B (1988) Long term renal prognosis of Henoch–Schönlein purpura in an unselected childhood population. Eur J Pediatr 147:113–115PubMedCrossRefGoogle Scholar
  10. 10.
    Roberti I, Reisman L, Churg J (1993) Vasculitis in childhood. Pediatr Nephrol 7:479–489PubMedCrossRefGoogle Scholar
  11. 11.
    Farine M, Poucell S, Geary DL, Baumal R (1986) Prognostic significance of urinary findings and renal biopsies in children with Henoch–Schönlein nephritis. Clin Pediatr (Phila) 25:257–259CrossRefGoogle Scholar
  12. 12.
    Rai A, Nast C, Adler S (1999) Henoch–Schönlein purpura nephritis. J Am Soc Nephrol 10:2637–2644PubMedGoogle Scholar
  13. 13.
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence-based medicine: what it is and what it isn’t. Br Med J 312:71–72Google Scholar
  14. 14.
    Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch S, Whitlock E (2007) Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med 147:117–122PubMedGoogle Scholar
  15. 15.
    Buchanec J, Galanda V, Belakova S, Minarik M, Zibolen M (1988) Incidence of renal complications in Henoch–Schönlein purpura syndrome in dependence of an early administration of steroids. Int Urol Nephrol 20:409–412PubMedCrossRefGoogle Scholar
  16. 16.
    Mollica F, Li Volti S, Garozzo R, Russo G (1992) Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140–144PubMedCrossRefGoogle Scholar
  17. 17.
    Reinehr T, Burk G, Andler W (2000) Does steroid treatment of abdominal pain prevent renal involvement in Henoch–Schönlein purpura? J Pediatr Gastroenterol Nutr 31:323–324PubMedCrossRefGoogle Scholar
  18. 18.
    Saulsbury FT (1993) Corticosteroid therapy does not prevent nephritis in Henoch–Schönlein purpura. Pediatr Nephrol 7:69–71PubMedCrossRefGoogle Scholar
  19. 19.
    Bayrakci US, Topaloglu R, Soylemezoglu O, Kalyoncu M, Ozen S, Besbas N, Bakkaloglu A (2007) Effect of early corticosteroid therapy on development of Henoch–Schönlein nephritis. J Nephrol 20:406–409PubMedGoogle Scholar
  20. 20.
    Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch–Schönlein purpura. BMC Med 2:7PubMedCrossRefGoogle Scholar
  21. 21.
    Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247PubMedCrossRefGoogle Scholar
  22. 22.
    Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, André C, Adnot S, Bonin P, Bierling P, Remy P, Lagrue G, Lang P, Weil B (1994) High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch–Schönlein purpura. Ann Intern Med 120:476–484PubMedGoogle Scholar
  23. 23.
    Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, André C, Adnot S, Bonin P, Bierling P, Remy P, Lagrue G, Lang P, Weil B (1995) Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch–Schönlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron 69:327–334PubMedCrossRefGoogle Scholar
  24. 24.
    Dixit MP, Dixit NM, Scott K (2004) Managing Henoch–Schönlein purpura in children with fish oil and ACE inhibitor therapy. Nephrology (Carlton) 9:381–386CrossRefGoogle Scholar
  25. 25.
    Sanai A, Kudoh F (1996) Effects of tonsillectomy in children with IgA nephropathy, purpura nephritis, or other chronic glomerulonephritides. Acta Otolaryngol Suppl 523:172–174PubMedGoogle Scholar
  26. 26.
    Inoue CN, Chiba Y, Morimoto T, Nishio T, Kondo Y, Adachi M, Matsutani S (2007) Tonsillectomy in the treatment of pediatric Henoch–Schönlein nephritis. Clin Nephrol 67:298–305PubMedGoogle Scholar
  27. 27.
    Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H (2003) Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch–Schönlein nephritis. Pediatrics 111:785–789PubMedCrossRefGoogle Scholar
  28. 28.
    Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein–Henoch purpura nephritis. Pediatr Nephrol 12:238–243PubMedCrossRefGoogle Scholar
  29. 29.
    Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch–Schönlein glomerulonephritis. Pediatr Nephrol 18:1138–1142PubMedCrossRefGoogle Scholar
  30. 30.
    Tarshish P, Bernstein J, Edelmann CM Jr (2004) Henoch–Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19:51–56PubMedCrossRefGoogle Scholar
  31. 31.
    Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch–Schönlein nephritis in children. Pediatr Nephrol 12:244–248PubMedCrossRefGoogle Scholar
  32. 32.
    Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB (2001) Treatment of Henoch–Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 21:128–133PubMedCrossRefGoogle Scholar
  33. 33.
    Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347–350PubMedGoogle Scholar
  34. 34.
    Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch–Schönlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864PubMedCrossRefGoogle Scholar
  35. 35.
    Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F (2007) Clinical outcome in children with Henoch–Schönlein nephritis. Pediatr Nephrol 22:64–70PubMedCrossRefGoogle Scholar
  36. 36.
    Bergstein J, Leiser J, Andreoli SP (1998) Response of crescentic Henoch–Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 49:9–14PubMedGoogle Scholar
  37. 37.
    Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375PubMedCrossRefGoogle Scholar
  38. 38.
    Singh S, Devidayal, Kumar L, Joshi K, Minz RW, Datta U (2002) Severe Henoch–Schönlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 22:133–137PubMedCrossRefGoogle Scholar
  39. 39.
    Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, Jeong HJ (2005) Cyclosporin A therapy for severe Henoch–Schönlein nephritis with nephrotic syndrome. Pediatr Nephrol 20:1093–1097PubMedCrossRefGoogle Scholar
  40. 40.
    Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ (2005) Can azathioprine and steroids alter the progression of severe Henoch–Schönlein nephritis in children? Pediatr Nephrol 20:1087–1092PubMedCrossRefGoogle Scholar
  41. 41.
    Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ (2006) Factors affecting histological regression of crescentic Henoch–Schönlein nephritis in children. Pediatr Nephrol 21:54–59PubMedCrossRefGoogle Scholar
  42. 42.
    Shin JI, Kim JH, Lee JS, Kim PK, Jeong HJ (2007) Methylprednisolone and cyclosporin therapy in a patient with nephrotic proteinuria. Indian J Pediatr 74:593–594PubMedCrossRefGoogle Scholar
  43. 43.
    Shenoy M, Ognjanovic MV, Coulthard MG (2007) Treating severe Henoch–Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 22:1167–1171PubMedCrossRefGoogle Scholar
  44. 44.
    Shin JI, Park JM, Lee JS, Kim JH, Kim PK, Jeong HJ (2006) Successful use of cyclosporin A in severe Schönlein–Henoch nephritis resistant to both methylprednisolone pulse and azathioprine. Clin Rheumatol 25:759–760PubMedCrossRefGoogle Scholar
  45. 45.
    Filler G, Hansen M, LeBlanc C, Lepage N, Franke D, Mai I, Feber J (2003) Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 18:445–449PubMedCrossRefGoogle Scholar
  46. 46.
    Gianviti A, Trompeter RS, Barratt TM, Lythgoe MF, Dillon MJ (1996) Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 75:186–190PubMedCrossRefGoogle Scholar
  47. 47.
    Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M (1999) Plasmapheresis as the sole therapy for rapidly progressive Henoch–Schönlein purpura nephritis in children. Am J Kidney Dis 33:427–433PubMedCrossRefGoogle Scholar
  48. 48.
    Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein–Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823PubMedCrossRefGoogle Scholar
  49. 49.
    Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H (2004) Plasmapheresis therapy for rapidly progressive Henoch–Schönlein nephritis. Pediatr Nephrol 19:920–923PubMedCrossRefGoogle Scholar
  50. 50.
    Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888PubMedCrossRefGoogle Scholar
  51. 51.
    Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C (2007) Effects of corticosteroid on Henoch–Schönlein purpura: a systematic review. Pediatrics 120:1079–1087PubMedCrossRefGoogle Scholar
  52. 52.
    Chartapisak W, Opastirakul S, Willis N, Craig JC, Hodson EM (2008) Prevention and treatment of renal disease in Henoch– Purpura: a systematic review. Arch Dis Child doi: 10.1136/adc.2008.141820

Copyright information

© IPNA 2008

Authors and Affiliations

  1. 1.Department of Mother-Child and Biology-GeneticsUniversity of VeronaVeronaItaly
  2. 2.Department of Paediatrics, Neonatal Intensive Care UnitUniversity of CagliariCagliariItaly

Personalised recommendations